Boehringer Avoids Pradaxa Trial, Board Chair Deposition With $650 Mil. Settlement
This article was originally published in The Pink Sheet Daily
Settlement expected to resolve approximately 4,000 Pradaxa personal injury claims.
You may also be interested in...
Bayer and Johnson & Johnson agree to resolve approximately 25,000 claims in federal and state courts for $775m, almost 13% of Xarelto's 2018 sales.
Philadelphia jurors find that warnings of bleeding risk with Xarelto are adequate, giving companies 5-0 litigation score; sixth trial in June.
Even after multiple bellweather wins, Janssen and Bayer still face claims they did not warn doctors about concomitant use with Plavix and aspirin; as case begins in Philadelphia, plaintiff's attorney tells jury the firms were 'silent,' while defense points to doctors' testimony that a different warning would not have changed their prescribing.